George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.10
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.20 (18.182%)
Open: 1.20
High: 1.20
Low: 1.20
Prev. Close: 1.20
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PRELIMINARY RESULTS FOR THE YEAR END

6 Dec 2017 08:11

RNS Number : 5299Y
Image Scan Holdings PLC
06 December 2017
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

PRELIMINARY RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2017

Image Scan (AIM: IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets, today announces preliminary results for the year ended 30 September 2017.

HIGHLIGHTS

· Total order intake for the year increased 25% to £5.4m (2016: £4.3m)

· Sales increased 50% to £5.0m (2016: £3.3m) at a gross margin of 38% (2016: 42%)

· Pre-tax trading profit increased 350% to £477k (2016: £105k)

· Closing order book of £2.1m (2016: £1.7m) and cash of £1.3m (2016 £1.1m)

· Portable X-ray systems sold extensively in Asia, the Middle East and Europe

· Growing sales to customers in the Indian subcontinent

· Compact portable X-ray detector developed and launched

· Continuing sales of industrial inspection systems

 

Bill Mawer, Chairman and Chief Executive of Image Scan, commented: "For a second consecutive year, sales of our range of portable X-ray systems to both current customers and first-time users increased considerably. We launched important new products and opened up promising new markets, a real team effort. I am also pleased with the continued progress in our supply chain and manufacturing processes, and with the growing library of positive feedback from users.

We started the new year with a record order book but have yet to finalise extended delivery dates on a portion of those orders. We continue to target large, multi-unit orders across our markets and this remains our primary short-term focus. In growing our order intake, we are focussed on diversifying our customer base, as in both our security and industrial businesses, a significant portion of the revenue is currently dependent on a small group of customers. In order to maximise the revenue from our well-developed route to market, we also plan to work towards adding new product lines to our portfolio during the coming year, beyond our current portable and industrial X-ray systems. This will be achieved through internal development, through partnerships or by acquisition and we can see opportunities in each of these areas."

 

-END-

Image Scan Holdings plc Tel: +44 (0) 1509 817400

William Mawer, Chairman

Sarah Atwell-King, Company Secretary

ir@ish.co.uk

 

Cantor Fitzgerald Europe Tel: +44 (0) 207 894 7000

Rick Thompson / David Foreman (Corporate Finance)

Alex Pollen / Caspar Shand Kydd (Sales)

 

About Image Scan Holdings plcImage Scan Holdings plc (AIM: IGE) is focused on the development and commercialisation of market leading real-time X-ray solutions for use in the global Security and Industrial inspection markets. The Company's Security portfolio includes the ThreatScan® range of portable bomb and suspect package detection systems; the Axis range of baggage inspection systems; and SVXi, a small vehicle inspection system. The Industrial inspection solutions include the MDXi product range, cabinet X-ray systems for laboratories and production lines. The Company was founded in 1996 and joined AIM in 2002.

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

CHAIRMANS STATEMENT

OVERVIEW

I am pleased to report on the results for Image Scan Holdings plc for the year ended 30 September 2017. The year saw substantial increases in both orders and sales and, with overheads under tight control, pre-tax profits grew strongly.

 

Order intake during 2017 totalled £5.4m (2016: £4.3m) and featured strong demand for portable X-ray systems. Revenue for the year was £5.0m (2016: £3.3m) and the business generated a pre-tax profit of £477k (2016: £105k). The Company closed the year with a record orderbook of £2.1m (2016: £1.7m) and a positive cash balance of £1.3m (2016: £1.1m).

 

In April the Company successfully raised £525k through a placing of 9,500,000 new ordinary shares at a price of 5.25 pence per share with new and existing institutional investors and a subscription of 500,000 new shares by William Mawer, Chairman and Chief Executive Officer, at the same price.

 

The Company's product strategy for the portable X-ray market has been to develop a modular and flexible systems that allows precise targeting of the performance requirements and budget availability in particular regional markets and for individual customer groups. That strategy has led to significant breakthroughs in markets in the Indian subcontinent with several new customers purchasing systems during the year, particularly the 'entry level' ThreatScan®-Lite system. Sales also grew in South East Asia and Europe.

 

Industrial X-ray systems, were delivered to manufacturing plants in the UK, Eastern Europe and South America and an important customer started to deploy the system into its global manufacturing centres after extensive trials at its European base.

An accelerated product development project led to the launch of the ThreatScan®-LS3, a new compact detector panel for use in portable X-ray systems. This system makes the technology of the ThreatScan®-LS1 available in the more compact package required by certain customer groups, notably the more mobile threat investigation teams. First customer deliveries were made in 2017. The decision to prioritise the LS3 development was driven by market demand and resulted in a delay in the launch of the Precision Linescan Detector ("PLD"). A second prototype of the PLD has now been built. The unit is currently being tested and was exhibited for the first time at the Milipol security show in Paris in November.

 

BUSINESS REVIEW

The number of portable X-ray systems sold increased by 65% in comparison to the prior year, much of the growth coming from markets in South East Asia and the Indian subcontinent. The year-end orderbook included over 80 portable systems, scheduled for delivery during FY2018. The majority of units sold were ThreatScan®-LS1 system following a major sales campaign during the prior year. That sales campaign has continued with units shown at major security equipment exhibitions and demonstrated at customer sites. However, several multi unit orders were received for the entry level ThreatScan®-Lite system. The launch of the compact ThreatScan®-LS3 system makes the technology and advanced image performance of the LS1 system available to users requiring a small imaging panel. It is now possible to provide a complete portable X-ray system in a backpack for users needing this flexibility.

Conveyor X-ray systems were sold to customers in the Middle East and a small number of MailScan systems from our UK manufacturing partner were sold to international customers.

The decision to prioritise the LS3 development was driven by market demand and resulted in a delay in the launch of the Precision Linescan Detector ("PLD"). This system has been developed with support of a grant from Innovate UK, the UK Government's innovation funding body. A second prototype of the PLD has been built, and is being tested. The system will be exhibited for the first time at the Milipol security show in Paris in November.

Industrial inspection systems, used for quality control in the manufacture of catalytic converters and diesel particulate filters in the automotive industry, were manufactured during the period and delivered to plants in UK, Eastern Europe and South America. We are working with our customers in this industry to explore and develop even more sophisticated testing regimes.

OPERATIONAL IMPROVEMENTS

In response to both the growing volume of sales and our desire to continue to improve on-time delivery and quality performance, we continued a strong drive for operational improvement in the Company and its processes. Manufacturing volume varied widely through the year and tight control of the manufacturing process allowed us to recruit and train temporary staff at peak periods with no loss of quality. The factory was re-laid out in the year, providing a 30% increase in capacity. There is further room for growth if required.

The support of the supply chain has also been important, and we now have a number of key suppliers working under framework contracts that allow us to call forward components as we need them rather than having to hold expensive stock in Image Scan or accept long lead times.

FINANCIAL RESULTS

The Company started the year with an order book of £1.7m (2016: £0.7m), won new orders worth £5.4m (2016: £4.3m) and made sales of £5.0m (2016: £3.3m), finishing the year with an order book of £2.1m (2016: £1.7m).

Gross margin on sales remained strong at 38% (2016: 42%). The small decrease reflected a change in product mix and selective use of aggressive pricing to break into new markets. Overheads increased to £1.5m (2016: £1.4m) and included substantial budgeted expenditure on both research and development and sales and marketing. This represented a relative decrease to 30% of sales (2016: 42% of sales).

Profit before tax increased to almost 10% of sales at £477k (2016: £105k).

The business finished the year with a positive cash balance of £1.3m (2016: £1.1m)

 

OUTLOOK

The Company starts 2018 with a robust orderbook, although we need to finalise the extended delivery dates on a proportion of those orders. The Company has an encouraging sales pipeline and a product range that allows a wide range of customers and markets to be addressed. Further portable X-ray product launches are planned during the year and these should allow the company to continue to extend its customer base. The security equipment market continues to be very active, reflecting the continuing high level of the terrorist threat, as portable X-ray systems are important tools for early detection/identification of a threat and often one of the first security technologies to be deployed after a threat is detected. We expect continuing healthy demand for these products.

 

We expect tighter legislation around vehicle emissions, particularly of diesel engines, to drive a continued focus on manufacturing quality in catalytic converters and diesel particulate filters. As a major supplier of automated X-ray inspection systems to this industry we expect these trends to continue to drive demand for our MDXi range of systems.

 

While the Company does receive valuable service and support revenue, this is its only recurring revenue. The Company has seen a growth in the number of support contracts in the year. The Company will be very focussed on maintaining the strong order intake of the last 18 months in order to continue the momentum recently established. We are considering adding additional resource to the sales team to support this effort.

 

The outlook for the Company remains positive in all its major markets with the key short-term focus being to drive sales and diversify our sources of revenue. Opportunities for further strategic expansion continue to be explored.

 

Over the next few years we intend to reinvest any profit made into the business and do not anticipate paying a dividend.

 

STAFF

The Board values greatly the considerable efforts made by our staff and, on behalf of the Directors, I would like to take this opportunity to personally thank staff and shareholders for their continued commitment to Image Scan.

 

 

William Mawer

CHAIRMAN

5 December 2017

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

Note

 

 

2017

£

2016

£

 

 

 

 

 

 

Continuing operations

 

 

 

 

 

 

 

 

 

 

 

REVENUE

3

 

 

5,033,636

3,314,806

Cost of sales

 

 

 

(3,104,007)

(1,911,046)

 

 

 

 

 

 

Gross profit

 

 

 

1,929,629

1,403,760

 

 

 

 

 

 

Other operating income

4

 

 

57,166

77,790

 

 

 

 

 

 

Operating expenses

Research and development expenses

 

 

 

(1,218,111)

(291,593)

(1,058,927)

(317,841)

 

 

 

 

 

 

Total administrative expenses

(1,509,704)

(1,376,768)

 

 

 

 

 

 

OPERATING PROFIT/(LOSS)

5

 

 

477,091

104,782

 

 

 

 

 

 

Finance income

 

 

 

286

671

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAXATION

 

 

 

477,377

105,453

 

 

 

 

 

 

Taxation

7

 

 

102,811

-

 

 

 

 

 

 

PROFIT AND TOTAL COMPREHENSIVE INCOME FOR THE YEAR FROM CONTINUING OPERATIONS ATTRIBUTABLE TO THE EQUITY OWNERS OF THE PARENT COMPANY

 

 

 

 

 

580,188

 

105,453

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pence

Pence

Earnings per share

8

 

 

 

 

Basic

 

 

 

0.45

0.08

Diluted

 

 

 

0.43

0.08

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

Note

 

 

2017

£

2016

£

NON-CURRENT ASSETS

 

 

 

 

 

Property, plant and equipment

9

 

 

26,842

16,796

 

 

 

 

 

 

 

 

 

 

26,842

16,796

CURRENT ASSETS

 

 

 

 

 

Inventories

11

 

 

1,094,879

504,584

Trade and other receivables

12

 

 

1,660,489

842,376

Cash and cash equivalents

13

 

 

1,253,114

1,054,588

 

 

 

 

 

 

 

 

 

 

4,008,482

2,401,548

 

 

 

 

 

 

TOTAL ASSETS

 

 

 

4,035,324

2,418,344

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

Trade and other payables

14

 

 

2,166,248

1,627,061

Warranty provision

15

 

 

47,977

51,232

 

 

 

 

 

 

 

 

 

 

2,214,225

1,678,293

 

 

 

 

 

 

NET ASSETS

 

 

 

1,821,099

740,051

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

 

Share capital

17

 

 

1,357,046

1,256,046

Share premium account

 

 

 

8,317,410

7,934,528

Retained earnings

 

 

 

(7,853,357)

(8,450,523)

 

 

 

 

 

 

TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS

 

 

 

1,821,099

 

740,051

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

CONSOLIDATED

Share capital

£

Share premium

£

Retained earnings

£

 

Total

£

As at 1 October 2015

 

1,256,046

7,934,528

(8,573,938)

616,636

Profit for the year and total comprehensive income/(expenditure) for the year

 

-

-

105,453

105,453

Share-based transactions

 

-

-

17,962

17,962

 

 

 

 

 

 

As at 30 September 2016

 

1,256,046

7,934,528

(8,450,523)

740,051

Shares issued during the year

 

101,000

426,000

-

527,000

Share issue Costs

 

-

(43,118)

 

(43,118)

Profit for the year and total comprehensive income/(expenditure) for the year

 

-

-

580,188

580,188

Share-based transactions

 

-

-

16,978

16,978

 

 

 

 

 

 

As at 30 September 2017

 

1,357,046

8,317,410

(7,853,357)

1,821,099

 

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

 

Note

 

2017

£

2016

£

 

Cash flows from operating activities

 

 

 

 

 

Operating profit before research and development expenditure

 

 

768,684

422,623

 

Research and development expenditure

 

 

(291,593)

(317,841)

 

 

 

 

 

 

 

Operating profit

 

 

477,091

104,782

 

Adjustments for:

 

 

 

Depreciation

 

 

12,975

6,215

 

Impairment of inventories

 

 

30,116

13,335

 

(Increase)/decrease in inventories

(620,411)

52,582

 

Increase in trade and other receivables

(715,301)

(458,695)

 

Increase in trade and other payables

 

 

539,186

849,168

 

(Decrease)/increase in warranty provisions

 

 

(3,255)

18,052

 

Share-based payments

 

 

16,978

17,962

 

 

 

 

 

 

 

Cash generated (used in)/from operating activities

 

 

(262,621)

603,401

 

Corporation tax recovered

 

 

-

-

 

 

 

 

 

 

 

Net cash flows (used in)/generated from operating activities

 

 

(262,621)

603,401

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

Interest received

 

 

286

671

 

Purchase of property, plant and equipment

 

9

 

(23,021)

(18,942)

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

 

 

(22,735)

 (18,271)

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

Proceeds from issue of share capital

 

 

 

527,000

-

 

Financial costs of fundraising

 

 

 

(43,118)

-

 

 

 

 

 

 

 

Net cash generated from financing activities

 

 

483,882

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Net INCREASE in cash and cash equivalents

198,526

585,130

 

Cash and cash equivalents at beginning of year

 

 

1,054,588

469,458

 

 

 

 

 

 

 

Cash and cash equivalents at end of year

13

 

1,253,114

1,054,588

 

 

 

 

 

 

 

 

Notes to the preliminary statement1. Basis of preparationThe financial information set out above does not constitute the Company's statutory accounts for the years ended 30 September 2017 and 30 September 2016 but is derived from those accounts. Statutory accounts for 2016 have been delivered to the Registrar of Companies, and those for 2017 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain statements under Section 498 of the Companies Act 2006.

2. IFRS 2 'Share-based payments'Operating expenses includes a charge of £16,978 (2016: £17,962) after valuation of the Company's employee share options schemes in accordance with IFRS 2 'Share-based payments'. Under this standard, the fair value of the options at the grant date is spread over the vesting period. These items have been added back in the statement of changes in equity.

3. .Earnings per share

Diluted profit per share is calculated by adjusting the weighted average number of ordinary shares in issue on the assumption of conversion of dilutive potential ordinary shares. The Company's dilutive potential ordinary shares are shares issued under the Company's Enterprise Management Incentive (EMI) scheme and options issued under the Company's Unapproved scheme.

 

 

 

 

 

2017

£

2016

£

 

 

 

 

 

 

 

 

Profit for the year

 

 

 

580,188

105,453

 

 

 

 

 

 

 

 

Weighted average number of ordinary shares in issue

 

 

129,512,227

125,604,577

 

 

 

 

 

 

 

 

Basic profit per share

 

 

 

0.45p

0.08p

 

Diluted profit per share

 

 

 

 0.43p

0.08p

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR VQLBBDLFBFBK
Date   Source Headline
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM
22nd Feb 20217:00 amRNSTrading Statement
15th Feb 202111:33 amRNSMello presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.